SCHEMBL1668690

SCHEMBL1668690

CCOC(=O)c1cnc(NC2CCC2=O)nc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.53
NPSR1 Q6W5P4 2/20 0.53
MAPT P10636 3/20 0.52
NPC1 O15118 2/20 0.52
ALDH1A1 P00352 3/20 0.47
PKM P14618 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
POLB P06746 1/20 0.44
JUN P05412 2/20 0.42
NFKB1 P19838 2/20 0.42
NFKB2 Q00653 2/20 0.42
RELA Q04206 2/20 0.42
FOS P01100 1/20 0.42
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41
CSNK1D P48730 1/20 0.40
PDE4B Q07343 2/20 0.40
IGF1R P08069 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24340552 0.79 MAPK8 (0.55) RAB9ANPSR1MAPTNPC1ALDH1A1
SCHEMBL19453365 0.76 RAB9A (0.65) RAB9ANPSR1MAPTNPC1ALDH1A1
SCHEMBL8398108 0.75 RAB9A (0.64) RAB9ANPSR1MAPTNPC1ALDH1A1
SCHEMBL28059191 0.71 CSNK1D (0.58) RAB9ANPSR1MAPTNPC1ALDH1A1
SCHEMBL15715130 0.70 KDM4E (0.40) RAB9ANPSR1MAPTNPC1ALDH1A1
SCHEMBL15688931 0.70 KDM4E (0.40) RAB9ANPSR1MAPTNPC1ALDH1A1
SCHEMBL30996914 0.70 RAB9A (0.56) RAB9ANPSR1MAPTNPC1ALDH1A1
SCHEMBL1669574 0.70 RAB9A (0.56) RAB9ANPSR1MAPTNPC1ALDH1A1
SCHEMBL18805081 0.70 RAB9A (0.54) RAB9ANPSR1MAPTNPC1ALDH1A1
SCHEMBL21480113 0.69 RAB9A (0.73) RAB9ANPSR1MAPTNPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9771345-B2 Coferons and methods of making and using them CORNELL UNIVERSITY (US) 2017-09-26 US disclosed
US-9771345-B2 Coferons and methods of making and using them CORNELL UNIVERSITY (US) 2017-09-26 US disclosed
US-9771345-B2 Coferons and methods of making and using them CORNELL UNIVERSITY (US) 2017-09-26 US disclosed
US-20120295874-A1 COFERONS AND METHODS OF MAKING AND USING THEM CORNELL UNIVERSITY (US) 2012-11-22 US disclosed
US-20120295874-A1 COFERONS AND METHODS OF MAKING AND USING THEM CORNELL UNIVERSITY (US) 2012-11-22 US disclosed
US-20120295874-A1 COFERONS AND METHODS OF MAKING AND USING THEM CORNELL UNIVERSITY (US) 2012-11-22 US disclosed
EP-2485678-A1 COFERONS AND METHODS OF MAKING AND USING THEM Cornell University (US) 2012-08-15 EP disclosed
WO-2011043817-A1 COFERONS AND METHODS OF MAKING AND USING THEM CORNELL UNIVERSITY (US) 2011-04-14 WO disclosed
WO-2011043817-A1 COFERONS AND METHODS OF MAKING AND USING THEM CORNELL UNIVERSITY (US) 2011-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120295874-A1 COFERONS AND METHODS OF MAKING AND USING THEM MYOF, FTH1, HCCS RAB9A 4270/4885NPSR1 1573/4885MAPT 2941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.